NAFTA | USMCA


US labor opposes USMCA in current form: official
The head of the largest US labor union said he opposes ratification of the new North American free trade pact, because he doubts Mexico will enforce labor reforms required by the deal.
Trump’s Nafta revisions offer modest economic benefits, report finds
A government report has concluded that the Trump administration’s revised North American trade agreement would offer modest benefits to the economy, challenging the president’s claims that the accord would make far-reaching changes.
Don’t fall for the hype of free trade agreements
NAFTA 2.0 is not about feeding people or doing right by American farmers or Canadian farmers or Mexican farmers—it is about furthering corporate profit.
Here’s what you need to know about CUSMA and digital trade
"The data localization and data transfer rules may erode efforts to safeguard privacy and many other provisions represent a lost opportunity to establish higher standards," says expert
Trump promised a new trade policy. But his new NAFTA might be worse than the old one
The intensifying debate over the renegotiated NAFTA that President Trump is seeking to rebrand as the United States-Mexico-Canada Agreement (USMCA) suggests that the president’s trade policy is not so different from those of his predecessors.
The new NAFTA deal is 'in trouble' amid looming elections, fights over tariffs
More than six months after the United States, Mexico and Canada agreed a new deal, the chances of the countries ratifying the pact in 2019 are receding.
Trump’s damaged NAFTA deal
USMCA bears many resemblances to NAFTA, which has been cited as a driver of low-wage corporate outsourcing.
Top House Democrat cites labor, enforcement concerns on new NAFTA
US House Speaker Nancy Pelosi said lawmakers could not take up the replacement for NAFTA unless Mexico passes legislation protecting workers’ rights. She also cited concerns over enforcement provisions, among other issues.
PBO report shows that new NAFTA provisions threaten Pharmacare, says Council of Canadians
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
Trump’s NAFTA 2.0 puts big pharma first, America second
The new version of NAFTA forbids the US Congress from curtailing Big Pharma’s patent monopolies on some of the world’s most expensive drugs.